Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Cedar Creek Partners. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+8.7%
Annualized+14.3%
Positioning StanceConstructive
Market CapMicroCap
GeographyUS
Digest Analysis
Quick Take
"Driven by expert market holdings up 35% and merger activity in community banks. Portfolio trades at 8.0x forward earnings with 35% expert market exposure generating alpha."
Executive Summary
Cedar Creek Partners delivered 8.7% net returns in Q1 2025 while major indices declined, with the fund's microcap and expert market focus driving outperformance. The portfolio trades at attractive valuations of 8.0 times forward earnings and 6.6 times earnings net of cash, with weighted price-to-book of 1.5 and dividend yield of 3.4%. Expert market exposure increased to 35% of the fund, generating 35% returns in the quarter. Key contributors included First IC's merger with MetroCity Bankshares at $22.58 per share and Western Capital Resources' tender offer at $15 per share. Defense holding Solitron Devices received record bookings of $20.8 million with major contracts from L3Harris and RTX. The manager maintains conviction in the strategy's ability to identify undervalued securities, with cash levels at 7% providing flexibility for new opportunities. Community bank holdings offer compelling value with Citizens Bancshares trading at seven times earnings despite massive overcapitalization.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
75%
CautiousHigh
High Conviction (75%)
High conviction demonstrated through concentrated positions, detailed fundamental analysis of holdings, and willingness to maintain significant expert market exposure despite liquidity constraints. Manager provides specific valuation metrics and catalysts for key positions.
Growth Outlook
25%
BearishBullish
Bearish (25%)
Manager expresses cautious optimism about the microcap opportunity set, noting attractive valuations and continued ability to find undervalued securities. However, acknowledges broader market headwinds with major indices declining significantly in Q1.
Risk Appetite
40%
DefensiveAggressive
Defensive (40%)
Portfolio maintains concentrated exposure to expert market stocks at 35% of fund, demonstrating moderate risk appetite. Cash levels decreased slightly from 8% to 7% indicating selective deployment, but no major position changes suggest measured approach.
Capital Deployment
15%
De-riskingDeploying
De-risking (15%)
Modest capital deployment with cash declining from 8% to 7%, representing minimal net activity. Added to existing positions and one new investment but no major sales, indicating selective and measured deployment pace.
Forward Guidance
30%
CautiousExpansionary
Cautious (30%)
Manager indicates continued focus on existing strategy with room for new members and additional capital deployment. Expresses confidence in current holdings but maintains selective approach to new investments.
Language Signal
35%
BearishBullish
Bearish (35%)
Language emphasizes attractive valuations, compelling opportunities, and superior returns, but balanced with acknowledgment of market challenges. Uses terms like 'incredibly attractive prices' and 'satisfactory returns' suggesting moderate optimism.
Perceived Risk
45%
Low RiskElevated
Moderate Risk (45%)
Manager acknowledges liquidity risks in expert market stocks and broader market volatility but views these as manageable within the strategy. Discusses specific risks around SEC regulations and market access constraints.
Opportunity Density
70%
ScarceAbundant
Abundant (70%)
Manager indicates abundant opportunities in microcap space, noting room for new capital and attractive valuations across holdings. Specific mention of having 'more attractive ideas than capital' suggests rich opportunity set.
Time Horizon
80%
Short-TermLong-Term
Decade+ (80%)
Long-term patient capital approach evidenced by willingness to hold illiquid expert market positions, multi-year investment horizons for key holdings, and focus on fundamental value realization over time rather than near-term catalysts.